LAIR1 and leukemia: Mice that received BM from isotype control–treated donors developed AML, while those that received BM from NC525-treated animals showed no propagation of leukemia, indicating that LAIR-1 engagement by NC525 eradicated LSCs within the BM of the PDX donor animals (Figure 3C).